Prim S.A. - Asset Resilience Ratio
Prim S.A. (PRM) has an Asset Resilience Ratio of 2.41% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read PRM current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2004–2025)
This chart shows how Prim S.A.'s Asset Resilience Ratio has changed over time. See PRM net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Prim S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PRM stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €4.75 Million | 2.41% |
| Total Liquid Assets | €4.75 Million | 2.41% |
Asset Resilience Insights
- Limited Liquidity: Prim S.A. maintains only 2.41% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Prim S.A. Industry Peers by Asset Resilience Ratio
Compare Prim S.A.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Teleflex Incorporated
NYSE:TFX |
Medical Instruments & Supplies | 4.50% |
|
Touchstone International Medical Science Co Ltd
SHG:688013 |
Medical Instruments & Supplies | 37.86% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
Crossject
PA:ALCJ |
Medical Instruments & Supplies | 1.31% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
Annual Asset Resilience Ratio for Prim S.A. (2004–2025)
The table below shows the annual Asset Resilience Ratio data for Prim S.A..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.41% | €4.75 Million ≈ $5.55 Million |
€196.53 Million ≈ $229.77 Million |
+0.25pp |
| 2024-12-31 | 2.16% | €4.12 Million ≈ $4.81 Million |
€190.28 Million ≈ $222.45 Million |
-1.24pp |
| 2023-12-31 | 3.40% | €6.81 Million ≈ $7.96 Million |
€200.10 Million ≈ $233.94 Million |
+1.18pp |
| 2022-12-31 | 2.22% | €4.11 Million ≈ $4.80 Million |
€184.99 Million ≈ $216.28 Million |
-0.17pp |
| 2021-12-31 | 2.39% | €4.29 Million ≈ $5.02 Million |
€179.85 Million ≈ $210.26 Million |
+0.32pp |
| 2020-12-31 | 2.07% | €3.39 Million ≈ $3.96 Million |
€163.64 Million ≈ $191.32 Million |
-1.14pp |
| 2019-12-31 | 3.21% | €4.80 Million ≈ $5.61 Million |
€149.66 Million ≈ $174.97 Million |
-2.62pp |
| 2018-12-31 | 5.83% | €8.06 Million ≈ $9.43 Million |
€138.31 Million ≈ $161.69 Million |
-0.23pp |
| 2017-12-31 | 6.06% | €8.35 Million ≈ $9.77 Million |
€137.77 Million ≈ $161.06 Million |
-5.76pp |
| 2016-12-31 | 11.82% | €15.17 Million ≈ $17.73 Million |
€128.29 Million ≈ $149.99 Million |
-1.20pp |
| 2015-12-31 | 13.02% | €15.14 Million ≈ $17.70 Million |
€116.21 Million ≈ $135.87 Million |
+9.23pp |
| 2014-12-31 | 3.79% | €4.42 Million ≈ $5.16 Million |
€116.54 Million ≈ $136.25 Million |
+2.98pp |
| 2013-12-31 | 0.81% | €874.40K ≈ $1.02 Million |
€108.55 Million ≈ $126.90 Million |
-16.06pp |
| 2012-12-31 | 16.87% | €17.69 Million ≈ $20.69 Million |
€104.89 Million ≈ $122.63 Million |
+16.63pp |
| 2011-12-31 | 0.24% | €279.68K ≈ $326.97K |
€117.88 Million ≈ $137.82 Million |
+0.11pp |
| 2010-12-31 | 0.13% | €145.50K ≈ $170.10K |
€110.75 Million ≈ $129.48 Million |
-0.46pp |
| 2009-12-31 | 0.59% | €591.10K ≈ $691.06K |
€99.98 Million ≈ $116.88 Million |
+0.40pp |
| 2008-12-31 | 0.19% | €177.82K ≈ $207.89K |
€94.04 Million ≈ $109.94 Million |
-0.13pp |
| 2007-12-31 | 0.32% | €274.51K ≈ $320.93K |
€85.75 Million ≈ $100.26 Million |
+0.21pp |
| 2006-12-31 | 0.11% | €94.16K ≈ $110.08K |
€82.44 Million ≈ $96.38 Million |
-0.98pp |
| 2005-12-31 | 1.10% | €859.81K ≈ $1.01 Million |
€78.42 Million ≈ $91.68 Million |
+1.08pp |
| 2004-12-31 | 0.02% | €12.09K ≈ $14.14K |
€66.06 Million ≈ $77.23 Million |
-- |
About Prim S.A.
Prim, S.A. operates as a health technology, mobility, and health care products provider in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic pr… Read more